|
MedKoo's special collection
Anticancer molecular libraries
Note: This webpage
will be completed in next few months, which
is being constructed mainly based on Dr. Qingqi Chen's new book entitled
"Anticancer Small Molecular Libraries"
ISBN: 9787030264473,
published by Science Press, Beijing,
China (Feb 2010).
Please visit this page shortly. Please inquire
any agents listed in our webpages.
AKT inhibitors
Anti-angiogenesis agents
Vascular disrupting agents
(VDAs)
VEGFR (PDGFR) inhibitors
EGFR (HER) inhibitors
Anti-metastasis agents
Anti-metabolite agents
Adenosine
deaminase inhibitors
Anti-folate agents
Purine-related anti-metabolite agents
Pyrimidine-related anti-metabolite agents
Ribonucleotide reductase inhibitors
TS inhibitors (thymidylate
synthase inhibitors)
Aurora
kinase inhibitors
BCL-2
inhibitors (B-Cell lymphoma 2 inhibitors)
BCR-ABL inhibitors
Bioreductive agents
CA inhibitors
(carbonic anhydrase inhibitors)
Cancer stem cell inhibitors
Cell cycle checkpoint inhibitors
CDK inhibitors (Cyclin-dependent kinase inhibitors)
c-Kit inhibitors
c-Met
inhibitor
Cyclooxygenase inhibitors
DNA targeting agents
DNA-cleaving agents
DNA-cross-linking agents
Aziridine-related
cross-linking agents
Bis-methylsulfate cross-linking agents
Cyclopropane-related cross-linking agents
Epoxide-related cross-linking agents
Nitrogen mustard
Nitrosourea mustard
Phosphoramide mustard
DNA intercalating agents
Anthraquinone-related
DNA
intercalating agents
Tetracyclic-related DNA
intercalating agents
DNA-PK inhibitors
DNA-sequence targeting agents
DNA G-quadruplex
stabilizers
DNA Monoalkylation agents
Platinum anticancer agents
Topoisomerase inhibitors
Acridine-related
topoisomerase inhibitors
Camptothecin-related topoisomerase inhibitors
Ellipticine-related
topoisomerase inhibitors
Naphthalimide-related
topoisomerase inhibitors
Naphthoquinone-related
topoisomerase inhibitors
Podophyllotoxin-related
topoisomerase inhibitors
Rebeccamycin-related
topoisomerase inhibitors
Thia-anthrone-related
topoisomerase inhibitors
Epigenetic-based therapeutic agents
Farnesyl transferase inhibitors
FLT3 inhibitors
(FMS-like tyrosine kinase 3 inhibitors)
HDAC inhibitors (Histone
deacetylase inhibitors)
Hormone-related anticancer agents
SERMs (selective estrogen-receptor
modulators)
Triphenylethylene-related SERMs
Steriod-related SERMs
Other-structure-related SERMs
SPRMs
(selective progesterone receptor modulators)
STS inhibitors
(Steroid sulfatase inhibitors)
Aromatase
inhibitors
Non-steroid aromatase inhibitors
Steroid aromatase inhibitors
LH-RH related agents
(luterinizing hormone-releasing hormone
related agents)
LH-RH
agonists (luterinizing hormone-releasing hormone agonists)
LH-RH receptor antagonists (luterinizing
hormone-releasing hormone antagonists)
Peptide-related LH-RH receptor antagonists
Non-peptide-related
LH-RH receptor antagonists
Anti-androgen agents
Steroid anti-androgen agents
Non-steroid anti-androgen agents
Somatostain-related anticancer agents
HSP inhibitors (heat shock protein inhibitors)
Hypoxia cytotoxic agents
IGF-IR inhibitors
(insulin-like growth factor I receptor inhibitors)
IMPDH
inhibitors (inosine 5'-monophosphate dehydrogenase inhibitors)
JAK inhibitors ( Janus Kinase Inhibitors)
JNK inhibitors (c-Jun
N-trminal kinase inhibitors)
KSP
inhibitors (Kinesin spindle protein inhibitors)
LTB4 receptor
antagonists (Leukotriene B4 antagonists)
MEK inhibitors
MGMT/AGT
inhibitors
Microtube inhibitors
Vinca alkaloids-related microtube inhibitors
Taxanes-related microtube inhibitors
Macrocyclic-related microtube inhibitors
Small peptides-related microtube inhibitors
Bicyclic-related microtube inhibitors
Benzenesulfonamide-related microtube inhibitors
Combrestatin-related microtube inhibitors
Benzophenone-related microtube inhibitors
Long-chain marine products-related microtube
inhibitors
MMP inhibitors
(Matrix metalloproteinase inhibitors)
mTOR inhibitors (mammalian target of rapamycin inhibitors)
MGMT/AGT inhibitors
Multiple kinase inhibitors
PARP
inhibitors (poly(adenosine diphosphate ribose) polymerase
inhibitors)
P-glycoprotein
inhibitors (MDR resistance
inhibitors)
Photodynamic therapy drugs (PDT drugs/photosensitizers)
Porphyrin-related PDT agents
Non-porphyrin-related PDT agents
PI3K inhibitors
(phosphoinisitide-3 kinase inhibitors)
PLK-1
inhibitors (Polo-like kinase inhibitors)
Proteasome inhibitors
Radiosensitizing agents
SPR modulators
(Selective progesterone receptor)
STAT3
inhibitors (signal transduction and activator of transcription
inhibitors)
Supportive care agents
Protective agents for chemotherapy and radiotherapy
Antiemetic agents
5-HT3 receptor antagonists
NK1 receptor antagonists
Cancer pain management agents
Survivin inhibitors
Targeted therapeutic agents
ADEPT agents (antibody director enzyme prodrug therapy agents)
GDEPT agents (Gene-directed enzyme prodrug therapy agents)
PDEPT agents (polymer-directed enzyme prodrug therapy agents)
Telomerase inhibitors
Thioredoxin reductase inhibitors
|
